{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:29:55Z","timestamp":1788985795215,"version":"build-2803163510"},"reference-count":45,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"unspecified","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Joint Funds for the innovation of Science and Technology\uff0c Fujian province","award":["2024Y9269"],"award-info":[{"award-number":["2024Y9269"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2025GGA021"],"award-info":[{"award-number":["2025GGA021"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82273415"],"award-info":[{"award-number":["82273415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82573518"],"award-info":[{"award-number":["82573518"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Talent Initiation Fund Project of Fujian Medical University Union Hospital","award":["2025XH017"],"award-info":[{"award-number":["2025XH017"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,6,29]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      CD161\n                      <jats:sup>+<\/jats:sup>\n                      CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, a cytotoxic T cell subset, remain poorly defined in terms of their clinical significance and functional role in esophageal squamous cell carcinoma (ESCC), which has limited the advancement of precision immunotherapy strategies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We integrated a multicenter cohort of ESCC patients who underwent either surgery or neoadjuvant therapy (chemotherapy or chemoimmunotherapy). Multiplex immunofluorescence staining, survival analyses, and assessment of major pathological response (MPR) and pathological complete response (pCR) were performed to elucidate the clinical relevance of CD161\n                      <jats:sup>+<\/jats:sup>\n                      CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell infiltration. The functional state and cellular interactions of this subset were characterized using single-cell RNA sequencing. A CT-based radiomics model was also developed for non-invasive prediction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      High intratumoral infiltration of CD161\n                      <jats:sup>+<\/jats:sup>\n                      CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells was identified as an independent prognostic factor for prolonged overall survival and disease-free survival (both p&lt;0.01) and appeared to correlate with a higher MPR and pCR rate following neoadjuvant therapy. This subset was enriched in treatment responders, exhibited transcriptional features associated with cytotoxicity and activation, and showed gene expression profiles suggestive of potential interactions with tumor-associated macrophages, possibly involving the TNFRSF9\/TNFSF9 (4-1BB\/4-1BBL) signaling axis. A radiomics model built on the XGBoost algorithm accurately predicted the infiltration level of this subset (area under the curve=0.889), and predicted high infiltration was correlated with favorable pathological response.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We identify CD161\n                      <jats:sup>+<\/jats:sup>\n                      CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells as a pivotal prognostic and predictive biomarker in ESCC. This subset is associated with a putative 4-1BB\/TNFSF9-mediated interaction network involving macrophages, correlating with a coordinated anti-tumor immune microenvironment. The CT-based radiomics model could provide a noninvasive means for assessing immune phenotypes, with potential applicability in patient stratification and treatment selection.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2026-014903","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:10:13Z","timestamp":1783595413000},"page":"e014903","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical significance of CD161\n                    <sup>+<\/sup>\n                    CD8\n                    <sup>+<\/sup>\n                    T cells in the tumor microenvironment of esophageal squamous cell carcinoma and their association with the 4-1BB signaling pathway"],"prefix":"10.1136","volume":"14","author":[{"given":"Shao-jun","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Fujian Medical University, Fuzhou, China"},{"name":"Fujian Medical University Union Hospital, Fuzhou, Fujian, China"},{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Fujian Medical University, Fuzhou, China"},{"name":"Fujian Medical University Union Hospital, Fuzhou, Fujian, China"},{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qiang","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Fujian Medical University, Fuzhou, China"},{"name":"Fujian Medical University Union Hospital, Fuzhou, Fujian, China"},{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Fujian Medical University, Fuzhou, China"},{"name":"Fujian Medical University Union Hospital, Fuzhou, Fujian, China"},{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-hua","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Hospital of Putian, Putian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ming","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Fujian Medical University, Fuzhou, China"},{"name":"Fujian Medical University Union Hospital, Fuzhou, Fujian, China"},{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-fan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Fujian Medical University, Fuzhou, China"},{"name":"Fujian Medical University Union Hospital, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Min","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Fujian Medical University, Fuzhou, China"},{"name":"Fujian Medical University Union Hospital, Fuzhou, Fujian, China"},{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Fujian Medical University, Fuzhou, China"},{"name":"Fujian Medical University Union Hospital, Fuzhou, Fujian, China"},{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Fujian Medical University, Fuzhou, China"},{"name":"Fujian Medical University Union Hospital, Fuzhou, Fujian, China"},{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Hospital of Putian, Putian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Xing","family":"Huang","sequence":"additional","affiliation":[{"name":"Pathology Department, The First Hospital of Putian City, Putian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3316-9908","authenticated-orcid":false,"given":"Shu Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China"},{"name":"Fujian Medical University, Fuzhou, China"},{"name":"Fujian Medical University Union Hospital, Fuzhou, Fujian, China"},{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"2026070904100651000_14.7.e014903.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01234-4"},{"key":"2026070904100651000_14.7.e014903.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032125"},{"key":"2026070904100651000_14.7.e014903.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30445-9"},{"key":"2026070904100651000_14.7.e014903.4","doi-asserted-by":"crossref","DOI":"10.1186\/s40880-019-0427-z","article-title":"The immune landscape of esophageal cancer","volume":"39","author":"Huang","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"2026070904100651000_14.7.e014903.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x"},{"key":"2026070904100651000_14.7.e014903.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6204"},{"key":"2026070904100651000_14.7.e014903.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0175-7"},{"key":"2026070904100651000_14.7.e014903.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.09.045"},{"key":"2026070904100651000_14.7.e014903.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914839107"},{"key":"2026070904100651000_14.7.e014903.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.09.015"},{"key":"2026070904100651000_14.7.e014903.11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc3196","article-title":"A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma","volume":"13","author":"Konduri","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026070904100651000_14.7.e014903.12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008694","article-title":"Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer","volume":"12","author":"Chen","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026070904100651000_14.7.e014903.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.11.014"},{"key":"2026070904100651000_14.7.e014903.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.035"},{"key":"2026070904100651000_14.7.e014903.15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25539-x","article-title":"Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"2026070904100651000_14.7.e014903.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-741041"},{"key":"2026070904100651000_14.7.e014903.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.008"},{"key":"2026070904100651000_14.7.e014903.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.003"},{"key":"2026070904100651000_14.7.e014903.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30789-X"},{"key":"2026070904100651000_14.7.e014903.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-018-0007-y"},{"key":"2026070904100651000_14.7.e014903.21","doi-asserted-by":"publisher","DOI":"10.1016\/J.CCELL.2021.04.014"},{"key":"2026070904100651000_14.7.e014903.22","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000161"},{"key":"2026070904100651000_14.7.e014903.23","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1423184","article-title":"Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome","volume":"7","author":"Braud","year":"2018","journal-title":"Oncoimmunology"},{"key":"2026070904100651000_14.7.e014903.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41698-020-00133-4","article-title":"The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma","volume":"4","author":"Li","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"2026070904100651000_14.7.e014903.25","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3909"},{"key":"2026070904100651000_14.7.e014903.26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705327114"},{"key":"2026070904100651000_14.7.e014903.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.11.014"},{"key":"2026070904100651000_14.7.e014903.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0522-3"},{"key":"2026070904100651000_14.7.e014903.29","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4466"},{"key":"2026070904100651000_14.7.e014903.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.10.038"},{"key":"2026070904100651000_14.7.e014903.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.02.005"},{"key":"2026070904100651000_14.7.e014903.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-024-01562-5","article-title":"The enhanced antitumor activity of bispecific antibody targeting PD-1\/PD-L1 signaling","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun Signal"},{"key":"2026070904100651000_14.7.e014903.33","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.217"},{"key":"2026070904100651000_14.7.e014903.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.008"},{"key":"2026070904100651000_14.7.e014903.35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/d41573-019-00214-5","article-title":"Immune agonist antibodies face critical test","volume":"19","author":"Garber","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"2026070904100651000_14.7.e014903.36","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27782"},{"key":"2026070904100651000_14.7.e014903.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.04.003"},{"key":"2026070904100651000_14.7.e014903.38","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30413-3"},{"key":"2026070904100651000_14.7.e014903.39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1038089","article-title":"Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors","volume":"13","author":"Park","year":"2022","journal-title":"Front Immunol"},{"key":"2026070904100651000_14.7.e014903.40","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.14110.1038\/nrclinonc.2017.141"},{"key":"2026070904100651000_14.7.e014903.41","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101348","article-title":"A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study","volume":"46","author":"Cui","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2026070904100651000_14.7.e014903.42","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S2589-7500(23)00082-1","article-title":"Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study","volume":"5","author":"Saad","year":"2023","journal-title":"Lancet Digit Health"},{"key":"2026070904100651000_14.7.e014903.43","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05392-4","article-title":"CT-based delta-radiomics nomogram to predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma patients","volume":"22","author":"Fan","year":"2024","journal-title":"J Transl Med"},{"key":"2026070904100651000_14.7.e014903.44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5989","article-title":"Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy","volume":"11","author":"Claus","year":"2019","journal-title":"Sci Transl Med"},{"key":"2026070904100651000_14.7.e014903.45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54877-9","article-title":"Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity","volume":"15","author":"Hamouda","year":"2024","journal-title":"Nat Commun"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-014903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:10:16Z","timestamp":1783595416000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-014903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,9]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/jitc-2026-014903"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-014903","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}